Institute of Human Virology Annual Meeting 2002-2004

人类病毒学研究所2002-2004年年会

基本信息

项目摘要

DESCRIPTION (provided by applicant): For six years the Annual Meeting of the Institute of Human Virology (Annual Meeting) has provided a forum for dedicated scientists in the fields of virology, most specifically HIV/AIDS, cancer biology and hematopoiesis, to present new data and exchange ideas and views. The Annual Meeting serves as a unique conference with the following aims: 1.To disseminate the most current research findings within the selected program topics; 2. To critically assess the impact of new findings on future directions for research; 3. To provide a forum for discussion of current and emerging issues; 4. To identify, support, and build the next generation AIDS researcher; 5. To increase participation by women, ethnic/racial minorities, and other individuals who have been traditionally under represented in science. The Institute of Human Virology (IHV), with the financial support requested in this application, will accomplish these aims: a) by attracting world renown senior scientists as presenters and participants; b) by carefully organizing each dedicated conference session with theoretically divergent perspectives and ethnically diverse participants; c) by enriching the scientific sessions with an open schedule to foster dialog and interaction between and among investigators; d) by reaching out to and promoting the participation of young investigators in poster sessions and scholarship initiatives; and e) by ensuring that conference results are shared with the broader scientific community through publication of all speaker and poster abstracts. Publication occurs in the Journal of Human Virology and the journal's website. The Annual Meeting is further strengthened by a strictly enforced press policy, one that protects data presented at the Annual Meeting for future peer-reviewed publication. This policy prohibits the members of the press from disclosing any information presented at the Annual Meeting without the permission of the presenter. An estimated 900 scientists and clinicians from around the world are expected to participate in this five-day meeting scheduled for September 9-13, 2002 at the Baltimore Marriott Waterfront Hotel. The Annual Meeting Scholarship Initiative provides funds and the poster session provides opportunities for the participation of promising junior researchers with a focus on outreach to women, and ethnic and racial minorities.
描述(由申请人提供):六年来,人类病毒学研究所年会(年会)为病毒学领域,特别是艾滋病毒/艾滋病、癌症生物学和造血学领域的专门科学家提供了一个论坛,展示新数据并交流想法和观点。年会是一次独特的会议,其目标如下: 1.传播所选项目主题内的最新研究成果; 2. 批判性地评估新发现对未来研究方向的影响; 3. 提供讨论当前和新出现问题的论坛; 4. 识别、支持和培养下一代艾滋病研究人员; 5. 增加妇女、少数民族和其他传统上在科学领域代表性不足的个人的参与。 人类病毒学研究所 (IHV) 在本申请中要求的财政支持下,将实现以下目标: a) 吸引世界知名的资深科学家作为演讲者和参与者; b) 精心组织每一次专门的会议,具有不同的理论观点和不同种族的参与者; c) 通过开放的时间表丰富科学会议,以促进研究者之间的对话和互动; d) 接触并促进年轻研究者参与海报会议和奖学金倡议; e) 通过出版所有演讲者和海报摘要,确保会议结果与更广泛的科学界共享。论文发表在《人类病毒学杂志》和该杂志的网站上。年会通过严格执行的新闻政策得到进一步加强,该政策保护年会上提交的数据以供未来同行评审出版物使用。该政策禁止新闻界人士未经演讲者许可披露在年会上演讲的任何信息。预计将有来自世界各地的 900 名科学家和临床医生参加定于 2002 年 9 月 9 日至 13 日在巴尔的摩万豪海滨酒店举行的为期五天的会议。年会奖学金计划提供资金,海报会议为有前途的初级研究人员提供参与机会,重点关注妇女、少数民族和少数族裔。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT C GALLO其他文献

ROBERT C GALLO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT C GALLO', 18)}}的其他基金

Durable Antibody Mediated Protection Against HIV
持久的抗体介导的艾滋病毒保护
  • 批准号:
    9141189
  • 财政年份:
    2016
  • 资助金额:
    $ 6.18万
  • 项目类别:
Admin-Core A
管理核心A
  • 批准号:
    9141190
  • 财政年份:
    2016
  • 资助金额:
    $ 6.18万
  • 项目类别:
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine
FLSC 与 Tat 类毒素联合作为 HIV 预防疫苗
  • 批准号:
    7854606
  • 财政年份:
    2009
  • 资助金额:
    $ 6.18万
  • 项目类别:
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine
FLSC 与 Tat 类毒素联合作为 HIV 预防疫苗
  • 批准号:
    8134640
  • 财政年份:
    2009
  • 资助金额:
    $ 6.18万
  • 项目类别:
FLSC Combined with Tat Toxoid as an HIV Prophylactic Vaccine
FLSC 与 Tat 类毒素联合作为 HIV 预防疫苗
  • 批准号:
    7944078
  • 财政年份:
    2009
  • 资助金额:
    $ 6.18万
  • 项目类别:
Polypeptide Microbicides Targeting CCR5
靶向 CCR5 的多肽杀菌剂
  • 批准号:
    6443774
  • 财政年份:
    2001
  • 资助金额:
    $ 6.18万
  • 项目类别:
Polypeptide Microbicides Targeting CCR5
靶向 CCR5 的多肽杀菌剂
  • 批准号:
    6658972
  • 财政年份:
    2001
  • 资助金额:
    $ 6.18万
  • 项目类别:
Polypeptide Microbicides Targeting CCR5
靶向 CCR5 的多肽杀菌剂
  • 批准号:
    6534391
  • 财政年份:
    2001
  • 资助金额:
    $ 6.18万
  • 项目类别:
MECHANISMS OF ACTION OF HAF--KAPOSI'S SARCOMA
HAF--卡波西肉瘤的作用机制
  • 批准号:
    6311551
  • 财政年份:
    2000
  • 资助金额:
    $ 6.18万
  • 项目类别:
Institute of Human Virology Annual Meeting 2005-2010
人类病毒学研究所2005-2010年年会
  • 批准号:
    7087025
  • 财政年份:
    1999
  • 资助金额:
    $ 6.18万
  • 项目类别:

相似海外基金

Roles of immune cells derived from clonal hematopoiesis in B-cell lymphomas
克隆造血来源的免疫细胞在 B 细胞淋巴瘤中的作用
  • 批准号:
    24K19213
  • 财政年份:
    2024
  • 资助金额:
    $ 6.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Genomic abnormalities in the tumor microenvironment and clonal hematopoiesis
肿瘤微环境和克隆造血的基因组异常
  • 批准号:
    23KK0149
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
High resolution lineage tracing of developmental hematopoiesis
发育造血的高分辨率谱系追踪
  • 批准号:
    10585400
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
解码正常和骨髓增生异常造血中的先天免疫信号
  • 批准号:
    10571337
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
Role of clonal hematopoiesis of indeterminate potential in development of calcific aortic valve stenosis
不确定潜能克隆造血在钙化性主动脉瓣狭窄发展中的作用
  • 批准号:
    23K07522
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibiting Thrombopoietin Receptor (TPO-R) Signaling as a Novel Approach to Target TET2 Mutation-Driven Clonal Hematopoiesis
抑制血小板生成素受体 (TPO-R) 信号传导作为靶向 TET2 突变驱动的克隆造血的新方法
  • 批准号:
    489650
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
    Operating Grants
Hyperlipidemia-induced Hematopoiesis is Repressed by MLKL in Endothelial Cells of the Splenic Niche
脾微环境内皮细胞中 MLKL 抑制高脂血症诱导的造血作用
  • 批准号:
    481044
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
Flow, Fatty Acid Biosynthesis, and Hematopoiesis
流动、脂肪酸生物合成和造血
  • 批准号:
    10868960
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
Identifying Inflammatory Mediators of Clonal Hematopoiesis
识别克隆造血的炎症介质
  • 批准号:
    10743540
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences
建立淋巴克隆造血的动态及其与衰老相关的疾病后果
  • 批准号:
    10713682
  • 财政年份:
    2023
  • 资助金额:
    $ 6.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了